AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
AAC Accepts, published online ahead of print on 26 December 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
AAC.01316-07v1
52/3/895    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rafii, F.
Right arrow Articles by Wagner, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rafii, F.
Right arrow Articles by Wagner, R. D.

 Previous Article  |  Next Article 

Antimicrob. Agents Chemother. doi:10.1128/AAC.01316-07
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Enhanced production of phospholipase C and perfringolysin O (alpha and theta toxins) in a gatifloxacin-resistant strain of Clostridium perfringens

Fatemeh Rafii*, Miseon Park, Amy E. Bryant, Shemedia J. Johnson, and Robert D. Wagner

National Center for Toxicological Research, U.S. FDA, Jefferson, AR, Veterans Affairs Medical Center, Boise, ID, University of Washington School of Medicine, Seattle, WA

* To whom correspondence should be addressed. Email: Fatemeh.Rafii{at}fda.hhs.gov.


   Abstract

Clostridium perfringens-induced gas gangrene is mediated by potent extracellular toxins, especially alpha toxin (a phospholipase C, PLC) and theta toxin (a thiol-activated cytolysin, perfringolysin O, PFO), and antibiotic-induced suppression of toxin synthesis is an important clinical goal. Production of PLC and PFO by a gatifloxacin-induced, fluoroquinolone-resistant mutant strain of C. perfringens Cp10G carrying a stable mutation in DNA gyrase was compared with that of the wild-type parent strain CpWT. Zymography (with sheep red blood cell and egg yolk overlays) and time-course analysis (with hydrolysis of egg-yolk lecithin and O-(4 nitrophenyl-phosphoryl)choline) demonstrated that Cp10G produced more PLC and PFO than CpWT. Increased toxin production in Cp10G was not related either to differences in growth characteristics between the wild type and the mutant strain or to non-synonymous polymorphisms in PLC, PFO or their known regulatory proteins. Increased PLC and PFO production by Cp10G was associated with increased cytotoxic activity for HT-29 human adenocarcinoma cells and with increased platelet/neutrophil aggregate formation. Four other gatifloxacin-induced gyrase mutants did not show increased toxin production, suggesting that gatifloxacin resistance was not always associated with increased toxin production in all strains of C. perfringens. This is the first report of increased toxin production in a fluoroquinolone-resistant strain of C. perfringens.







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.